Our Recommendations
New Publications
- Séquençage génomique du SARS-CoV-2 à des fins de santé publique : orientations provisoires, 8 janvier 2021 (2021)
- Guidance for SARS-CoV-2 samples selection for genomic characterization and surveillance (2021)
- SARS-CoV-2 genomic sequencing for public health goals: Interim guidance, 8 January 2021 (2021)
- Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health (2021)
- Secuenciación del genoma del SARS-CoV-2 con fines de salud pública: orientaciones provisionales, 8 de enero de 2021 (2021)
Filter
14
Featured
New Publications
6
Language
Document type
Guidelines
10
Manuals
3
Resource Platforms
1
Countries / Regions
Latin America and the Carribbean
2
Russia
2
Middle East and North Africa
1
Brazil
1
Authors & Publishers
Publication Years
Category
COVID-19
5
Virology
4
General Guidelines
1
Policies
1
Guidelines
1
Toolboxes
Genomic sequencing
14
Laboratory Guidance
4
Diagnostics & Laboratory Guidance
4
Surveillance
2
Surveillance & Contact tracing
2
Country specific documents
2
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
Genomic sequencing has been an essential tool in generating virological data, driving the laboratory response, and better understanding the dispersal and evolutionary patterns of SARS-CoV-2. In addition to the characterization of the global circulation patterns, early detection of SARS-CoV-2 variant...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
En el último decenio, los datos de las secuencias genéticas de los patógenos han adquirido un papel crucial en la detección y el manejo de los brotes de enfermedades infecciosas, contribuyendo al desarrollo de pruebas diagnósticas, medicamentos y vacunas y orientando la respuesta sanitaria.
WHO-2019-nCoV-genomic_sequencing
Representative, quality, timely and continuous genetic surveillance of SARS-CoV-2 is critical to the COVID-19 outbreak response. This document provides practical guidance to Global Influenza Surveillance and Response System (GISRS) laboratories and other relevant national laboratories to move beyond...
Sequencing SARS-CoV-2 in the Americas
The COVID-19 Genomic Surveillance Regional Network was created in 2020 not only to strengthen the sequencing capacity in the participating laboratories, but also for them to establish a routine SARS-CoV-2 genomic sequencing, as a strategy to increase the amoun...
Orientações para a vigilância em saúde, no que se refere aos aspectos epidemiológicos e laboratoriais da vigilância genômica da covid-19
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...
